de Verneuil et al24 recently published about genetically modified hematopoietic stem cells, with a lentivirus-mediated vector, allowing the normal expression of the UROS gene to proceed to a bone marrow transplantation in a murine model of CEP. The gene discussed is UROS; the disease is cutaneous porphyria.